Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening. Ornnork N, Kiriwan D, Lirdprapamongkol K, Choowongkomon K, Svasti J, Eurtivong C*. J Mol Graph Model. 2020 Sep;99:107639.

01 Sep 2020
0
0

Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening.

Ornnork N, Kiriwan D, Lirdprapamongkol K, Choowongkomon K, Svasti J, Eurtivong C*.

J Mol Graph Model. 2020 Sep;99:107639.

Tags

Share this

Related Posts

Gerhauser, C., Klimo, K., Heiss, E., Neumann, I., Gamal-Eldeen, A., Knauft, J., . . . Frank, N. (2003). Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat Res, 523-524, 163-172. doi:10.1016/s0027-5107(02)00332-9
01 Feb 2003
0

Gerhauser, C., Klimo, K., Heiss, E., Neumann, I., Gamal-Eldeen, A., Knauft, J., . . . Frank, N. (2003). Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat Res, 523-524, 163-172. doi:10.1016/s0027-5107(02)00332-9

Gerhauser, C., Klimo, K., Heiss, E., Neumann, I., Gamal-Eldeen, A., Knauft, J., . . . Frank, N. (2003). Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat Res, 523-524, 163-172. doi:10.1016/s0027-5107(02)00332-9
View More

Recent Posts